In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of 10x Genomics Inc (NASDAQ: TXG) was $8.27 for the day, up 3.31% from the previous closing price of $8.01. In other words, the price has increased by $3.31 from its previous closing price. On the day, 3.36 million shares were traded. TXG stock price reached its highest trading level at $8.515 during the session, while it also had its lowest trading level at $8.11.
Ratios:
Our analysis of TXG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.26 and its Current Ratio is at 4.97. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on February 13, 2025, Downgraded its rating to Market Perform and sets its target price to $12 from $25 previously.
On September 03, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $35.
Jefferies Upgraded its Hold to Buy on July 22, 2024, while the target price for the stock was maintained at $24.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 28 ’25 when Saxonov Serge sold 7,942 shares for $10.63 per share. The transaction valued at 84,393 led to the insider holds 871,540 shares of the business.
Serge Saxonov bought 7,942 shares of TXG for $83,947 on Feb 28 ’25. On Feb 24 ’25, another insider, Hindson Benjamin J., who serves as the insider of the company, sold 4,573 shares for $11.07 each. As a result, the insider received 50,603 and left with 335,324 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 1012049024 and an Enterprise Value of 701258752. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.66 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 1.148 whereas that against EBITDA is -4.479.
Stock Price History:
The Beta on a monthly basis for TXG is 1.92, which has changed by -0.73133117 over the last 52 weeks, in comparison to a change of 0.07019031 over the same period for the S&P500. Over the past 52 weeks, TXG has reached a high of $36.15, while it has fallen to a 52-week low of $6.78. The 50-Day Moving Average of the stock is -22.07%, while the 200-Day Moving Average is calculated to be -48.43%.
Shares Statistics:
TXG traded an average of 3.07M shares per day over the past three months and 3661950 shares per day over the past ten days. A total of 108.24M shares are outstanding, with a floating share count of 100.79M. Insiders hold about 17.59% of the company’s shares, while institutions hold 83.15% stake in the company. Shares short for TXG as of 1743379200 were 12059140 with a Short Ratio of 3.93, compared to 1740700800 on 13768808. Therefore, it implies a Short% of Shares Outstanding of 12059140 and a Short% of Float of 12.870000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
